New Multilayer Flask Enhances Cell Culture Production
![](/46/pdcnewsitem/03/33/60/VhX6Xz82a80yw5U.jpg)
Porvair Sciences has announced a new 5-layer cell culture flask developed to fulfil the need of the growing number of applications that require large numbers of cells.
While single layer flasks are well proven for small-scale cell culture scale up, their use can become laborious and time-consuming when large numbers of cells are required. Offering a sterile growth area of 870 cm2 in a compact footprint, Porvair's new 5-layer cell culture flask offers a high performance solution to this application need.
Porvair cell culture flasks combine the unrivalled optical purity of high-pressure moulded 100% USP Class VI virgin crystal polystyrene with a patented low-pressure gas plasma surface treatment that allows cells to adhere more efficiently to the surface by reducing its hydrophobicity. Highly polished moulds and rigorous quality control ensure that you get perfect visualisation every time.
The new 5-layer cell culture flasks provide easy pipette access for direct addition of reagents and cells as well as efficient recovery of valuable cells and reagents thereby reducing the risk of contamination due to pouring.
Porvair cell culture flasks are made to the highest international standards for material quality, surface optical polish, tissue culture treatment, sterility and pack integrity. All products are certified to be free from DNase/RNase and Pyrogen contamination. Investment in UK based laboratory testing ensures that you receive consistently high quality products.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance